William Baumel is listed as a director on 3 SEC Form D filings by 2 issuers between Jul 2022 and Jan 2024: eFuse, Inc. (Columbus, OH — other technology — 2022; $981.7M reported sold to 49 investors) and Clarametyx Biosciences, Inc. (Columbus, OH — biotechnology — 2024; $27.5M reported sold to 7 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $1.01B sold in total.
Listed alongside Brian Jonard (2 shared filings), Matthew Benson (2 shared filings), Neil Duffy (2 shared filings), Chuck Bramlage (1 shared filing), David Richards (1 shared filing) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around William. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for William Baumel and found 5 differences, 1 worth asking the sponsor about: Amount sold went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.